UNSPSC 51341803: Darunavir ethanolate

This classification denotes a protease inhibitor C27H37N3O7S.C2H6O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 33O78XF0BW, chemically known as ((1s,2r)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)- carbamic acid (3r,3as,6ar)-hexahydrofuro(2,3-b)furan-3-yl ester monoethanolate, but more generally known as darunavir ethanolate, which bears US NIH Compound Identifier 23725083.

UNSPSC 51341803 Darunavir ethanolate, a Commodity code, represents state and local procurement of specific antiretroviral pharmaceutical products. The recent opportunity record shows activity misaligned with the code's nominal scope: the Illinois Department of Public Health's awarded contract (Solicitation 26482DPHPREPDB53392, completed August 28, 2026) supplied Doxycycline Hyclate and Ciprofloxacin Hydrochloride tablets, not darunavir ethanolate. Seminole County, Florida's open solicitation (IFB60459723LAS, posted June 30, 2026, due July 26, 2023) sought Naloxone and drug deactivation systems for community health initiatives. Neither opportunity aligns with the antiretroviral product specified by the code, indicating limited relevant recent activity under this specific commodity classification within state and local procurement.

The available records reflect state-level departments and county health authorities as issuing bodies, with geographic activity spanning Illinois and Florida. No open solicitations for darunavir ethanolate appear in the recent opportunity block, and the two posted records represent different pharmaceutical categories entirely. State and local procurement under this code shows little current activity matching its intended scope; buyers appear to tag pharmaceutical purchases under varying commodity codes regardless of active substance, making targeted business development under this specific code difficult to support with current market signals.